BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36794502)

  • 21. CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.
    Sakamoto Y; Ishida T; Masaki A; Murase T; Ohtsuka E; Takeshita M; Muto R; Iwasaki H; Ito A; Kusumoto S; Nakano N; Tokunaga M; Yonekura K; Tashiro Y; Iida S; Utsunomiya A; Ueda R; Inagaki H
    Hematol Oncol; 2022 Dec; 40(5):876-884. PubMed ID: 36043457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation.
    Fuji S; Yamaguchi T; Inoue Y; Utsunomiya A; Moriuchi Y; Uchimaru K; Owatari S; Miyagi T; Taguchi J; Choi I; Otsuka E; Nakachi S; Yamamoto H; Kurosawa S; Tobinai K; Fukuda T
    Haematologica; 2017 Jul; 102(7):1258-1265. PubMed ID: 28341734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group.
    Itonaga H; Taguchi J; Fukushima T; Tsushima H; Sato S; Ando K; Sawayama Y; Matsuo E; Yamasaki R; Onimaru Y; Imanishi D; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Honda S; Miyazaki Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):607-15. PubMed ID: 23333533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma.
    Katsuya H; Yamanaka T; Ishitsuka K; Utsunomiya A; Sasaki H; Hanada S; Eto T; Moriuchi Y; Saburi Y; Miyahara M; Sueoka E; Uike N; Yoshida S; Yamashita K; Tsukasaki K; Suzushima H; Ohno Y; Matsuoka H; Jo T; Suzumiya J; Tamura K
    J Clin Oncol; 2012 May; 30(14):1635-40. PubMed ID: 22473153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adult T cell leukemia-lymphoma with allo-HSCT after treatment for pulmonary involvement with Mogamulizumab].
    Kawashima I; Sueki Y; Yamamoto T; Nozaki Y; Nakajima K; Mitsumori T; Kirito K
    Rinsho Ketsueki; 2015 Feb; 56(2):210-5. PubMed ID: 25765802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study.
    Ito A; Nakano N; Tanaka T; Fuji S; Makiyama J; Inoue Y; Choi I; Nakamae H; Nagafuji K; Takase K; Machida S; Takahashi T; Sawayama Y; Kamimura T; Kato K; Kawakita T; Ogata M; Sakai R; Shiratori S; Uchimaru K; Inamoto Y; Utsunomiya A; Fukuda T
    Blood Adv; 2021 Oct; 5(20):4156-4166. PubMed ID: 34500464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of adult T-cell leukemia.
    Uozumi K
    J Clin Exp Hematop; 2010; 50(1):9-25. PubMed ID: 20505272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma.
    Kataoka K; Koya J
    J Clin Exp Hematop; 2020 Sep; 60(3):66-72. PubMed ID: 32779615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult T-Cell Leukemia-Lymphoma.
    Munakata W; Tobinai K
    Cancer Treat Res; 2019; 176():145-161. PubMed ID: 30596217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
    Yasuda S; Najima Y; Konishi T; Yamada Y; Nagata A; Takezaki T; Kaito S; Kurosawa S; Sakaguchi M; Harada K; Shingai N; Yoshioka K; Inamoto K; Mukae J; Toya T; Igarashi A; Shimizu H; Kobayashi T; Kakihana K; Sakamaki H; Kawamata N; Ohashi K; Doki N
    Leuk Res; 2021 Sep; 108():106627. PubMed ID: 34062327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma].
    Utsunomiya A
    Rinsho Ketsueki; 2016; 57(10):2190-2198. PubMed ID: 27795530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for ATL with HTLV-1 Antibody-Positive Donors.
    Yoshimitsu M; Fuji S; Utsunomiya A; Nakano N; Ito A; Ito Y; Miyamoto T; Suehiro Y; Kawakita T; Moriuchi Y; Nakamae H; Kanda Y; Ichinohe T; Fukuda T; Atsuta Y; Kato K;
    Biol Blood Marrow Transplant; 2020 Apr; 26(4):718-722. PubMed ID: 31821886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic alterations in adult T-cell leukemia/lymphoma.
    Kogure Y; Kataoka K
    Cancer Sci; 2017 Sep; 108(9):1719-1725. PubMed ID: 28627735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Successful treatment with tucidinostat in a patient with relapsed adult T-cell leukemia/lymphoma following allogeneic hematopoietic stem cell transplantation].
    Moriki A; Ito S; Horikita F; Tsutsumi Y
    Rinsho Ketsueki; 2024; 65(1):18-23. PubMed ID: 38311384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma.
    Kameda T; Shide K; Tahira Y; Sekine M; Sato S; Ishizaki J; Takeuchi M; Akizuki K; Kamiunten A; Shimoda H; Toyama T; Maeda K; Yamashita K; Kawano N; Kawano H; Hidaka T; Yamaguchi H; Kubuki Y; Kitanaka A; Matsuoka H; Shimoda K
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
    Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K;
    Cancer Sci; 2020 Dec; 111(12):4567-4580. PubMed ID: 32976684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
    Katsuya H; Ishitsuka K
    J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A decision analysis comparing unrelated bone marrow transplantation and cord blood transplantation in patients with aggressive adult T-cell leukemia-lymphoma.
    Fuji S; Kurosawa S; Inamoto Y; Murata T; Utsunomiya A; Uchimaru K; Yamasaki S; Inoue Y; Moriuchi Y; Choi I; Ogata M; Hidaka M; Yamaguchi T; Fukuda T
    Int J Hematol; 2020 Mar; 111(3):427-433. PubMed ID: 31701480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/Lymphoma.
    Iyama S; Sato T; Ohnishi H; Kanisawa Y; Ohta S; Kondo T; Mori A; Tsutsumi Y; Kuroda H; Kakinoki Y; Yamamoto S; Takahashi T; Shindo M; Torimoto Y; Sato K; Iwasaki H; Haseyama Y; Kohda K; Nagamachi Y; Hirayama Y; Sakai H; Hirata Y; Fukuhara T; Ikeda H; Kobune M; Kato J; Kurosawa M
    Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):23-30.e2. PubMed ID: 27727135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Outcomes of Patients with Adult T Cell Leukemia-Lymphoma in a Nonendemic Metropolitan Area: A Retrospective Analysis of the Population-Based Osaka Cancer Registry.
    Fuji S; Kida S; Morishima T; Nakata K; Miyashiro I; Ishikawa J
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1433-1438. PubMed ID: 32417489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.